Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

| Jul 27, 2016
| 3:32 PM EDT
Markets in rally mode as Fed once again decides to leave rates unchanged in 9-1 vote.   Some big moves...
| Jul 27, 2016
| 11:04 AM EDT
Market other than the NASDAQ, which is being driven by better than expected results from Apple (AAPL), has giv...
| Jul 26, 2016
| 11:34 AM EDT
Market slightly down as we head towards noon.  Oil continues its slide and now below $43 a barrel.  ...
It has been great standing in for Doug Kass today. Evidently, Monday has a more engaged investor audience than my usual Friday beat. There were more than 200 comments today in a very lively back-and-forth session. It made what was a dull trading day much more enjoyable, so thanks to all who participated.

Where Is the Insider Buying? Real Money Pro($)

The market is off its worst levels of the day. Big biotech and biopharma are providing strength today, with Biogen (BIIB) , Gilead Sciences (GILD) and Mylan (MYL) all sporting solid gains in a down market. Energy has made a bit of a comeback, but still is down nearly 2% on the day.
Macy's (M) , which has been quite strong recently. The company's real estate is probably worth more than the stock's market value, while M offers a good dividend and solid management. Rival retailer Urban Outfitters (URBN) has started to recover over the past month. You'd think that U.S. consumer spending should be solid given America's low energy prices, near-full employment and wage gains that are accelerating somewhat. Gilead Sciences (GILD) , which reports after the bell tonight. I think investors are too worried about sliding U.S. sales of the firm's hepatitis C drug. After all, the stock sports more than a 12% free-cash-flow yield and goes for just 7x earnings despite a 2% dividend yield.

I'm Bullish on Biotechs Real Money Pro($)

The market continues to trade lower as we late morning, with Tobira Therapeutics (TBRA) serving as the "disaster du jour" in the small-cap biotech space.

Energy Stocks Lack Much Power Real Money Pro($)

Markets are slightly down to begin the trading day, while oil continues to slump and is closer to $40 a barrel than $50 again.

I'm Hot on Housing Stocks Real Money Pro($)

It looks from the futures like we're in for a flattish opening to begin the trading week.

Bret Jensen Reporting for Duty Real Money Pro($)

Good morning! Bret Jensen here.

Columnist Conversations

You should try to snare from TWLO within a few points of here as that will be the derivative play off of FB to...
Interface (TILE) posted 32-cents in its Q2 period versus a 28-cent consensus estimate.  Revenues also ...
Markets in rally mode as Fed once again decides to leave rates unchanged in 9-1 vote.   Some big moves...
UPS will be reporting its 2nd quarter results before Friday's opening bell.  The stock has been fading si...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.